Groowe Groowe / Newsroom / MRK
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

MRK News

Merck & Co., Inc.

Lead Chemicals Research Report 2026: $1.76 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

globenewswire.com
MRK

Global Kaposi's Sarcoma Market Accelerates with Rising HIV/AIDS Prevalence and Innovative Treatments

globenewswire.com
BMY PFE MRK BAX

Merck en ChemLex ondertekenen een memorandum van overeenstemming ter bevordering van geautomatiseerde chemie en technologische innovatie USA - Nederlands USA - Deutsch USA - Français Vietnam - Vietnamese USA - English APAC - English Japan - Japanese Korea

prnewswire.com
MRK

Single-Use Bioprocessing Market Projected to Reach US$ 122.92 Billion by 2035, Supported by Expansion of Biomanufacturing Capacity Says Astute Analytica

globenewswire.com
TMO AMGN PFE BMY GILD REGN AZN LLY MRK GSK

Immunomic Therapeutics Announces FDA Clearance of IND Application for a UNITE®-Based Self-Amplifying RNA Vaccine for Triple-Negative Breast Cancer, to Be Studied Alone and in Combination with Keytruda®

businesswire.com
MRK

Neon-22 Market Research Report 2026: $3.25+ Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

globenewswire.com
LIN MRK

Beyond Benign’s Green Chemistry Commitment Earns 2025 RSC Horizon Prize for Education for Advancing Green Chemistry in Higher Education

accessnewswire.com
MRK

Merck et ChemLex signent un protocole d'accord pour faire progresser la chimie automatisée et l'innovation technologique USA - Français USA - English APAC - English USA - Deutsch

prnewswire.com
MRK

Merck und ChemLex unterzeichnen Absichtserklärung zur Förderung der automatisierten Chemie und technologischen Innovation USA - Deutsch APAC - English USA - English

prnewswire.com
MRK

BioVaxys Reports Positive Clinical Study Results from Phase 1B/2 PESCO Trial of MVP-S with Pembrolizumab (Keytruda (TM)) and Low-Dose Cyclophosphamide for Patients with Recurrent Epithelial Ovarian Cancer (EOC) Ready to Announce with Confidence?

newsfilecorp.com
MRK BMY